✍ Scribed by Humin Wang; William H. Rodgers; Michael J. Chmell; Chris Svitek; Herbert S. Schwartz
No coin nor oath required. For personal study only.
Fifteen archival human osteosarcoma specimens were examined by in situ hybridization for the expression of human and mouse transforming growth factor‐β (isoforms 1, 2, and 3), c‐fos, and metalloproteinase (stromelysin‐3 and matrilysin). Osteosarcoma subtypes were confirmed by review of patients' radiographs, histopathology, and age at diagnosis. The outcome and method of treatment were documented. The subtypes of osteosarcoma consisted of nine conventional osteosarcomas and two each of fibroblastic, telangiectatic, and post‐radiation osteosarcomas. Each specimen was histologically examined under light microscopy, and then adjacent paraffin sections were assayed with sense and anti‐sense RNA probes by in situ hybridization. The probes localized to the neoplastic cells, confirming the methodology of the technique. Human transforming growth factor‐β1 had the most uniform binding affinity to the osteosarcomas examined and was more specific in binding than mouse transforming growth factor‐β1. Specific mRNA encoding for the transforming growth factor‐βs, c‐fos, and metalloproteinases are detectable in patterns within osteosarcoma cells, and collectively, their expression parallels the different histopathologic subtypes. The less differentiated subtypes (telangiectatic and post‐radiation osteosarcomas) expressed the fewest molecular markers. Osteosarcoma is a heterogeneous tumor. Differential expression of matrilysin in osteosarcoma is the first reported detection of metalloproteinase activity in human skeletal sarcoma.
📜 SIMILAR VOLUMES
## Abstract The objective of this study was to investigate the role of the MET oncogene in canine osteosarcoma. Seven large‐breed dogs affected by spontaneous skeletal osteosarcoma underwent __en bloc__ tumor excision. Total RNA was extracted from frozen tumor samples and assessed for expression of
Initial approaches to prenatal diagnosis from fetal karyotyping involved application of standard cytogenetic techniques. However, when fetal samples, such as chorionic villus cells or amniocytes are used, small chromosome rearrangements cannot be easily identified because they lack a distinct bandin